UTI Drops 8.5% on Q4 Miss as $35M Expansion Slashes FY27 Guidance
Universal Technical Institute fell 8.5% to $20.17 after a Q4 earnings miss and aggressive FY27 expansion spending triggered a sharp guidance cut.

Shares of Universal Technical Institute (NYSE: UTI) tumbled 8.5% to $20.17 on Thursday after the vocational training provider reported a sharp fourth-quarter earnings miss and slashed its fiscal 2027 profit outlook. For investors, management’s decision to absorb $35 million in upfront expansion spending marks an unexpected multi-quarter earnings drought, putting near-term returns on hold to fund ambitious 2029 targets.
What happened
For its fourth fiscal quarter ended September 30, 2026, UTI generated revenue of $235.9 million, up 6.0% year-over-year. However, diluted earnings per share slumped to $0.32, falling well short of the $0.52 expected by Wall Street consensus. Full-year fiscal 2026 net income dropped 46.7% to $33.6 million, primarily impacted by strategic growth investments and elevated depreciation, alongside margin pressure from staff turnover in high school admissions and capacity bottlenecks across core automotive and diesel programs.
The true shock landed in the company's fiscal 2027 forecast on its income statement and cash flow. Management projected full-year diluted EPS of just $0.00 to $0.09 on net income of zero to $5 million, trailing analyst estimates of $0.73 by a wide margin. While fiscal 2027 revenue is guided to grow modestly to $925 million–$945 million, UTI will incur approximately $35 million in adjusted EBITDA headwinds to fund four new campus openings—including Salt Lake City and Concorde sites in Houston, Atlanta, and Glendale—and roll out more than 15 program expansions.
Why it matters
The market reaction illustrates the harsh penalty investors impose when growth-oriented capital allocation clashes with quarterly profit visibility. Chief Executive Officer Jerome Grant is betting heavily on Phase II of the company’s "North Star" roadmap, targeting $1.2 billion in revenue and $220 million in adjusted EBITDA by fiscal 2029.
Yet reaching that horizon requires capital expenditures of $160 million to $170 million in fiscal 2027 alone. By essentially wiping out GAAP net profit for an entire fiscal year, UTI has rewritten its near-term valuation ratios. Investors who bought into steady post-acquisition margin expansion are now asked to underwrite a costly execution bridge where returns may not materialize until fiscal 2028 or beyond.
What to watch next
- Admissions stabilization: Whether new student starts hit the projected 34,000–35,500 range after Q4's deceleration to 3.3% growth.
- Campus launch milestones: Regulatory approvals and construction progress for the four new facilities slated for fiscal 2027.
- Capital discipline: Free cash flow burn and debt levels as capital expenditures ramp toward $170 million.
- Q1 FY27 earnings: Early progress reports on pre-opening operating costs and margin pressure due in February 2027.
Sources (2)
This analysis is for information only and is not investment advice. Prices and figures as of publication.